QNRX

Quoin Pharmaceuticals, Ltd.

There isn't enough reported data to score QNRX yet.

QNRX Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

QNRX's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

QNRX PE Valuation

QNRX has no meaningful PE right now: it lost money over the past year.

QNRX Forward outlook

There aren't enough analyst estimates for QNRX to show an outlook.

QNRX Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $3.75 on Nov 12.

There is not enough scenario data to assess QNRX's risk to reward.

QNRX Earnings Per Share

Q2 2024: $-8.67Q3 2024: $-7.19
Q2 2024: $-8.67Q3 2024: $-7.19

QNRX Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

QNRX Free Cash Flow

Q4 2023: โˆ’$3MQ1 2024: โˆ’$1MQ2 2024: โˆ’$2MQ3 2024: โˆ’$2MQ4 2024: โˆ’$2MQ1 2025: โˆ’$3MQ2 2025: โˆ’$4MQ3 2025: โˆ’$2MQ4 2025: โˆ’$5MQ1 2026: โˆ’$5MQ2 2026: โˆ’$3MQ3 2026: โˆ’$6M
Q4 2023: โˆ’$3MQ1 2024: โˆ’$1MQ2 2024: โˆ’$2MQ3 2024: โˆ’$2MQ4 2024: โˆ’$2MQ1 2025: โˆ’$3MQ2 2025: โˆ’$4MQ3 2025: โˆ’$2MQ4 2025: โˆ’$5MQ1 2026: โˆ’$5MQ2 2026: โˆ’$3MQ3 2026: โˆ’$6M
QuarterFree cash flowYoY
Q3 2026-$5.8M-$3.5M
Q2 2026-$3.1M+$542K
Q1 2026-$4.9M-$2.3M
Q4 2025-$5M-$2.8M
Q3 2025-$2.2M-$46.2K
Q2 2025-$3.7M-$1.7M
Q1 2025-$2.6M-$1.2M
Q4 2024-$2.2M+$987.1K

QNRX has burned cash in almost every quarter: โˆ’$19M over the past year, against โˆ’$11M the year before.

QNRX Total Shares

Q4 2023: 987,220Q1 2024: 4MQ2 2024: 4MQ3 2024: 5MQ4 2024: 9MQ4 2025: 52MQ3 2026: 173M
Q4 2023: 987,220Q1 2024: 4MQ2 2024: 4MQ3 2024: 5MQ4 2024: 9MQ4 2025: 52MQ3 2026: 173M
PeriodChange %Net change
Quarterly+230%+121M shares
1 year+4246%+169M shares

QNRX has 173M diluted shares, up 4246% from a year ago.

QNRX Net Leverage

QNRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

QNRX Weekly Momentum

MetricValueStatus
RSI39.4Neutral
Stochastic8.6Oversold

QNRX's weekly RSI is 39 (neutral) and its Stochastic is 9 (oversold).

QNRX PE vs Healthcare Sector

QNRX has no meaningful PE right now: it lost money over the past year.

QNRX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.4115% below
20 week MA$5.0025% below
50 week MA$6.7645% below
100 week MA$8.8358% below

QNRX is in a downtrend: it's below all four of its weekly moving averages, and 58% below its 100-week average.

QNRX Yearly ROI

YearStart priceEnd priceROI
2024$25.9$19.3-26%
2025$19.3$14.0-27%
2026 YTD$14.0$3.75-73%

QNRX has finished every year since 2024 lower, and it's down 73% so far in 2026.

Give your agent the market.

Get API key